Weekly treatment with insulin efsitora is noninferior to daily insulin degludec for the reduction of HbA1c in adults with type 1 diabetes, show the findings of the QWINT-5 trial.
Put your clinical decision-making skills to the test with these interactive cases. Examine the factors crucial for incorporating CGM into a patient-centric approach to managing diabetes.
Genetic testing was needed to diagnose mitochondrial disorder MIDD in a woman with diabetes, weight loss and poor glycemic control. Glycated hemoglobin and pancreatic function improved after treatment with a DPP-4 inhibitor.
Many patients are yet to benefit from the advances and approaches now at our disposal for the management of type 2 diabetes. How can the gaps and delays be addressed?
People with type 2 diabetes who are on a total diet replacement program can achieve remission in the real-world setting, but with lower frequency than in clinical trials.
Our tailored content service will keep you up to date…
Receive newsletters curated for the busy specialist by our expert editorial team
Weekly treatment with insulin efsitora is noninferior to daily insulin degludec for the reduction of HbA1c in adults with type 1 diabetes, show the findings of the QWINT-5 trial.
With the growing importance of primary care in diabetes, this podcast discusses the evidence on continuous glucose monitoring (CGM) use, the role of primary healthcare, and practical tips for interpreting the ambulatory glucose profile (AGP) report.
Genetic testing was needed to diagnose mitochondrial disorder MIDD in a woman with diabetes, weight loss and poor glycemic control. Glycated hemoglobin and pancreatic function improved after treatment with a DPP-4 inhibitor.
A rare case of fulminant type 1 diabetes induced by SJS/TEN, which had developed in a patient taking carbamazepine and phenytoin. Glucose monitoring should be considered for patients with SJS/TEN.
The GLP-1 receptor agonist dulaglutide was unintentionally used by a woman with type 2 diabetes until the third trimester of an unplanned and unrecognized pregnancy, but what was the outcome?
Type 1 diabetes (T1D) is characterized by the progressive destruction of insulin-producing beta cells in the pancreas. Despite improvements in insulin monitoring techniques, there remains no cure for T1D. Individuals with T1D require lifelong …
While elevated low-density lipoprotein (LDL) cholesterol has been the primary concern for cardiologists and lipidologists for many years, the cardiovascular outcomes of patients achieving very low levels of LDL cholesterol (e.g., less than 50 …
Diabetes is a chronic health condition characterized by increased blood glucose levels, arising from insufficient insulin production by the pancreas, ineffective cellular response to insulin, or a combination of both [ 1 ]. In 2021, diabetes has …
Folic acid was first isolated from spinach in 1941. Since then, folic acid has been called by many different names, including vitamin B9, folate, vitamin M, and the scientific name pteroylglutamic acid [ 1 , 2 ]. Although the terms folic acid and …
Despite many recent advances in its management, type 1 diabetes remains a burden for those living with the condition.
Prof. Chantal Mathieu explains the progress being made with disease-modifying therapy for type 1 diabetes and how it has the potential to transform the current treatment landscape.
Refine the application of CGM technology in primary care to enhance the management of type 2 diabetes. Benefit from key updates and experiential learning using CGM devices, and practice your clinical decision-making skills.
Stay up to date with the rapidly changing CGM landscape. Learn how to implement and integrate CGM into diabetes management to improve patient care and outcomes.
Expert guidance on the multidisciplinary approach to identifying and managing chronic kidney disease in patients with type 2 diabetes, plus patient scenarios to assist your decision-making and put the latest clinical guidelines into context.
This program is not available to users in the UK and US.
Type 2 diabetes is a chronic metabolic disease characterized by elevated blood glucose levels, affecting more than 537 million adults worldwide in 2021 [ 1 ]. In Saudi Arabia, diabetes has a particularly high prevalence, affecting more than 17.5% …
Physique athletes undergo rigorous competition preparation with intense energy restriction and physical training to enhance muscle definition. This preparatory phase is followed by a recovery period of 3–4 months, during which body composition and …
Sarcopenia, defined as the loss of skeletal muscle mass and strength with aging [ 1 ], has serious physiological and clinical consequences, such as falls, fractures, cognitive impairment, hospitalization, and mortality [ 2 – 4 ]. Patients with type …
People with diabetes are at high risk of cardiovascular (CV) and kidney diseases, contributing to most of the diabetes-related morbidity and mortality [ 1 , 2 ]. Owing to the established safety and efficacy of sodium-glucose co-transporter-2 …
Weekly treatment with insulin efsitora is noninferior to daily insulin degludec for the reduction of HbA1c in adults with type 1 diabetes, show the findings of the QWINT-5 trial.
Weekly treatment with insulin efsitora is noninferior to daily insulin degludec for the reduction of HbA1c in adults with type 1 diabetes, show the findings of the QWINT-5 trial.
Many patients are yet to benefit from the advances and approaches now at our disposal for the management of type 2 diabetes. How can the gaps and delays be addressed?
Weekly treatment with insulin efsitora is noninferior to daily insulin degludec for the reduction of HbA1c in adults with type 1 diabetes, show the findings of the QWINT-5 trial.
